| 注册
首页|期刊导航|中国临床药理学杂志|前列康片治疗Ⅲ型前列腺炎的临床研究

前列康片治疗Ⅲ型前列腺炎的临床研究

杨非衡 肖飞 姚雯 高运生

中国临床药理学杂志Issue(9):765-766,2.
中国临床药理学杂志Issue(9):765-766,2.DOI:10.13699/j.cnki.1001-6821.2014.09.004

前列康片治疗Ⅲ型前列腺炎的临床研究

Clinical efficacy of Qianliekang tablets on typeⅢprostatitis

杨非衡 1肖飞 2姚雯 3高运生1

作者信息

  • 1. 北京市朝阳区社区卫生服务管理中心,北京100026
  • 2. 北京市垂杨柳医院,北京100022
  • 3. 北京市朝阳区卫生局,北京 100026
  • 折叠

摘要

Abstract

Objective To evaluate the clinical efficacy of Qianliekang tablets on typeⅢprostatitis.Methods A total of 105 patients with typeⅢprostatitis were enrolled in this study.All patients took 2 g Qianliekang tablets each time for 6 weeks, three times a day.With National Instituted of Health -chronic prostatitis symptom index ( NIH-CPSI ) scores and expressed prostatic secretious ( EPS ) as evaluating indexes , they were compared before and after treatment.Results The total effective rate of Qianliekang tablets was 84.3%after six weeks of treatment.There were sig-nificant statistical differences in NIH-CPSI scores and the amount of leuko-cyte in EPS between before treatment and six weeks after treatment ( P<0.05).Conclusion The results of this study have demonstrated that Qian-liekang tablets has a definite clinical effect on treating type Ⅲprostatitis.

关键词

Ⅲ型性前列腺炎/前列康片/慢性前列腺炎症状指数/前列腺液

Key words

type Ⅲ prostatitis/Qianliekang tablets/National Instituted of Health -chronic prostatitis symptom index/expressed prostatic secre-tious

分类

医药卫生

引用本文复制引用

杨非衡,肖飞,姚雯,高运生..前列康片治疗Ⅲ型前列腺炎的临床研究[J].中国临床药理学杂志,2014,(9):765-766,2.

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文